Christian U. Blank
Leiden University Medical Center · 684 works · 60,260 citations · h-index 96
Top works
- Pembrolizumab versus Ipilimumab in Advanced Melanoma
- Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
- Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
- PD-L1/B7H-1 Inhibits the Effector Phase of Tumor Rejection by T Cell Receptor (TCR) Transgenic CD8+ T Cells
- Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
- Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
- B cells and tertiary lymphoid structures promote immunotherapy response
- A randomized controlled comparison of pembrolizumab and chemotherapy in patients with ipilimumab-refractory melanoma
- Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006)
- Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion
- The human tumor microbiome is composed of tumor type–specific intracellular bacteria
- Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study
- Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy
- MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study
- Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma
- Blockade of PD‐L1 (B7‐H1) augments human tumor‐specific T cell responses in vitro
- LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells
- Anti–CTLA-4 therapy broadens the melanoma-reactive CD8 + T cell response
- The “cancer immunogram”
- Defining ‘T cell exhaustion’